Analysis of Mabion S.A. (MAB)
Mabion S.A. is showing some interesting trends based on the provided data:
1. Price Movement: The closing prices for Mabion S.A. have been fluctuating between 16.66 and 308.00, indicating significant price volatility.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values are mostly around 47-52, suggesting that the stock is neither overbought nor oversold.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values vary, with some positive and negative values, indicating potential shifts in momentum.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values are also fluctuating, reflecting the changing price trends.
3. Overall, Mabion S.A. seems to be experiencing price volatility with no clear trend direction. Traders and investors may need to closely monitor the stock for potential trading opportunities based on technical indicators and moving averages.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in revenue from FY 2022 to FY 2023.
- Prior to the decrease, there was a consistent increase in revenue from FY 2020 to FY 2022.
- Overall, there has been significant growth in revenue over the past four years, despite the recent decrease.
These trends in revenue can provide insights into the company's performance and market conditions over the specified period.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist mainly of investments and advances, which have been increasing steadily.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown variations but has generally been positive, indicating a healthy financial position.
6. The company has been relying on a mix of short-term and long-term debt to finance its operations.
7. The provision for risks and charges has been relatively stable over the years.
8. Accumulated depreciation has been significant, affecting the value of non-current assets.
9. The company has been investing in machinery, furniture, and equipment as part of its non-current assets.
10. Overall, the financial health of the company seems stable, with a focus on investments and managing liabilities.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a return on assets of 22.07% and return on equity of 147.25%. The company's fiscal year ends on September 30, 2023.
Regarding stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The stock is held by insiders at 5.22% and institutions at 57.59%, with a short percent of shares outstanding at 0.65%.
Valuation metrics show a PEG ratio of 26.32, forward P/E of 26.32, and trailing P/E of 29.59. The enterprise value is $2.95 trillion, with a market capitalization of $2.92 trillion. The price to book ratio is 39.34, price to sales ratio is 7.65, enterprise to EBITDA ratio is 22.76, and enterprise to revenue ratio is 7.73.
In the stock price summary, the beta is 1.26, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The stock's 52-week low is $164.08, high is $199.62, and the change over the past 52 weeks is 6.85%.
Lastly, in dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend yield of 0.53%. The dividend date is May 16, 2024, with an ex-dividend date of May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73%, and the trailing annual dividend yield is 0.51%.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests further growth compared to the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the previous year's same quarter. The number of analysts providing estimates remains at 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates remains at 38.
Overall, the analysts are forecasting moderate to strong sales growth for both the upcoming quarters and the next fiscal year, with the highest growth expected in the next fiscal year ending in September 2025.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight decrease in growth rate compared to the past 5 years but still showing healthy growth prospects in the near future.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these figures, we can see that the analysts have a wide range of opinions on the future price of the security, with a low estimate of $164 and a high estimate of $275. The median and average forecasts are $201.43 and $204.58 respectively. The current price of the security is $192.25. It appears that the analysts are generally optimistic about the future price of the security, with the average and median forecasts both higher than the current price.MACD of MAB